Development of a nomogram based on serum cytokine-related riskscore in breast cancer.

Zhu, Ye; He, Yang; Chen, Chong; Zhang, Jingyi; Yang, Xin; Lu, Yuqing; Chen, Yong-Zi; Zhao, Weipeng

Zhu, Ye; He, Yang; Chen, Chong; Zhang, Jingyi; Yang, Xin; Lu, Yuqing; Chen, Yong-Zi; Zhao, Weipeng.

Afiliación

Zhu Y; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
He Y; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Chen C; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Zhang J; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Yang X; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Lu Y; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Chen YZ; Department of Breast Cancer, Tianjin Cancer Hospital Airport Hospital, Tianjin, China.
Zhao W; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Front Oncol ; 13: 1146463, 2023.

Article en En | MEDLINE | ID: mdl-37007080

Palabras clave

breast cancer; cytokine; nomogram; prognosis; riskscore

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google